End-of-year resolutions? Xeltis is hiring!

2022-12-22T18:40:30+01:00December 22nd, 2022|Latest News|

If joining a truly innovative medtech company may be part of your end-of-year resolutions, we have good news for you: Xeltis is hiring! We are expanding our device development and clinical trial programs and scaling up our R&D, Clinical [...]

Professor Moll presents aXess at VEITH

2022-11-18T18:34:09+01:00November 18th, 2022|Latest News|

Professor Frans Moll, University Medical Center Utrecht, will update an audience of international vascular surgeons at the VEITH Symposium in New York City this Saturday. In a session on new technologies for vascular access creation, Professor Moll will provide [...]

Xeltis starts the pivotal clinical trial for aXess

2022-11-10T09:24:27+01:00November 10th, 2022|Latest News|

Xeltis has started the pivotal trial for the first-ever restorative synthetic hemodialysis access grafts, aXess. The first two patients have been successfully implanted, as part of the AXESS European pivotal trial at AZ Sint-Jan Brugge-Oostende AV in Bruges, Belgium [...]

Go to Top